Please login to the form below

Not currently logged in
Email:
Password:

Allergan opens Indian pharma R&D arm

US-headquartered Allergan has opened its first pharmaceutical R&D facility in India

According to local media reports, US-headquartered Allergan has opened its first pharmaceutical R&D facility in India.

The Allergan Pharmaceutical Development Centre India, which will make up part of Allergan's worldwide R&D operations, will focus on implementing global pharmaceutical R&D projects conducted in the region.

According to Scott M Whitcup, Allergan's worldwide executive vice-president of R&D, the centre would have 15 clinical research and data management personnel at the start of operations and could double within two years.

Whitcup said that Allergan's estimated investment for the new centre at USD 3m to USD 5m over the next few years. He added that R&D activities at the centre would initially focus on therapies in areas such as inflammatory and infective conditions of the eye, movement disorders and urological indications.

The centre is Allergan's third largest outside of the US. The company also has Allergan India, which manages the commercial side of Allergan's business there.

8th August 2007

Share

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
11 London

11 London is a strategic and creative agency working in the fields of health and humanity – complex areas, but...

Latest intelligence

What’s in it for me? How to engage, motivate and support staff with internal training at OPEN Health
...
Environmental impact of in-person vs. virtual meetings
Although it will be tempting to resume in-person activities in the same capacity as before, we need to weigh the pros and cons of virtual vs. in-person vs. hybrid events...
US biosimilars
The US celebrates five years of biosimilars on the market – a look to the past, present and future
Why the success of biosimilars in the US has been mixed...

Infographics